Prelude Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
19,072
-4,918
| -21% | -$262K | 0.1% | 255 |
|
|
2025
Q1 | $971K | Buy |
23,990
+6,118
| +34% | +$248K | 0.07% | 260 |
|
|
2024
Q4 | $497K | Buy |
17,872
+1,572
| +10% | +$43.7K | 0.03% | 505 |
|
|
2024
Q3 | $468K | Buy |
+16,300
| New | +$468K | 0.03% | 583 |
|
|
2023
Q4 | – | Sell |
-11,243
| Closed | -$569K | – | 980 |
|
|
2023
Q3 | $569K | Buy |
+11,243
| New | +$569K | 0.04% | 350 |
|